Effect of BAY 59–7939—a novel, oral, direct Factor Xa inhibitor - on clot-bound Factor Xa activity in vitro - Depasse, F; Busson, J; Mnich, J; Le Flem, L; Gerotziafas, G T; Samama, M M
J Thromb Haemost 2005;3(Suppl 1):Abstract P1104